期刊文献+

人免疫缺陷综合征治疗药物研究进展 被引量:1

Development of curative drugs of human acquired immunodeficiency syndrome
下载PDF
导出
机构地区 解放军第
出处 《西南国防医药》 CAS 2005年第1期107-110,共4页 Medical Journal of National Defending Forces in Southwest China
  • 相关文献

参考文献12

  • 1王临旭,孙永涛,杨为松.核糖体失活蛋白抗HIV的研究进展[J].国外医学(流行病学.传染病学分册),2002,29(2):67-70. 被引量:10
  • 2郑葆芬.白血病病毒、人免疫缺陷综合征病毒、癌基因[M].上海:上海医科大学出版社,1996.65-81. 被引量:1
  • 3De Clercq E.Antiviral drugs:current state of art [J].J Clin Virol,2001,22(1):73-89. 被引量:1
  • 4Harris M,Montaner JSG.Clinical uses of non2nucleoside reverse transcriptase inhibitors[J].Rev Med Virol,2000,10:217-229. 被引量:1
  • 5Smith PF,DiCenzo R,Morse GD.Clinical pharmacokinetics of nonnucleoside reverse transcriptase inhibitors[J].Clin Pharmacokinet,2001,40(12):893-905. 被引量:1
  • 6GadiB,Dom inique A,M arka W,ET al.The thicarboxanilide nonnucleoside inhibitor UC781 resto resantiviral activity of (AZT)againt AZT-resistant human immunodeficiency virus type 1[J].Antimicrob Agent Chemother,1999,43(2):259. 被引量:1
  • 7Barreiro P,Soriano V,Blanco F,et al.Risks and benefits of replacing protease inhibitors by nevirapine in HIV2infected subjects under longterm successful triple combination therapy[J].AIDS,2000,14(7):807-812. 被引量:1
  • 8Rober Craigie.HIV integrase,a brief overview from chemistry to therapeutics[J].J Biol Chem,2001,276(26):23213-23216. 被引量:1
  • 9Hazucla DJ,Felock P,Witmer M,et al.Inhibitor of strand transfer that prevent integration and inhibit HIV21 replication in cells [J].Science,2000,287(5453):646-650. 被引量:1
  • 10Boycl MR.Gustafson KR,Mcmahon JB,et al.Discovery of cyanovirin-N,a novel human immun o-deticiency virus inactivating protein that binds virus surface envelope gp120:potential applications to microbicide development [J].J antimicrob Agents Chemother,1997,41(7):1521-1526. 被引量:1

二级参考文献15

  • 1Putnam CD et al. Nat Struct Biol,2000;7(1):17-18 被引量:1
  • 2Wang YX et al. Cell,1999;99(4):433-442 被引量:1
  • 3Nicolas E et al. J Biol Chem, 1998;273:17216- 17220 被引量:1
  • 4Barbieri L et al. Biochim Biophys Acta, 1993; 1154: 237 - 282 被引量:1
  • 5Mayer RA et al. Eur J Clin Inves, 1992;22(2):113-122 被引量:1
  • 6Lee-Huang S et al. FEBS Lett, 1991,;291:139-144 被引量:1
  • 7Lee-Huang S et al. Gene ,1995 ;161:151-156 被引量:1
  • 8Lee-Huang S et al. Proc Natl Acad Sci USA, 1991;88:6570-6574 被引量:1
  • 9Ng TB et al. Gen Pharmacol,1992;23(4) :579- 590 被引量:1
  • 10Lee-Huang S et al. Proc Natl Acad Sci USA,1995;92:8818 - 8822 被引量:1

共引文献9

同被引文献15

  • 1马立艳,许淑珍,马纪平.肠球菌致病机制的研究进展[J].中华医院感染学杂志,2005,15(3):356-360. 被引量:47
  • 2吴利先,黄文祥.粪肠球菌sprE基因的功能研究[J].中华微生物学和免疫学杂志,2005,25(10):841-841. 被引量:6
  • 3吴利先,黄文祥.sprE基因敲除粪肠球菌突变株的构建和功能的初步研究[J].中国人兽共患病学报,2006,22(9):828-832. 被引量:7
  • 4马贵军,韩素娟,剡根强,周霞,王静梅.肠球菌毒力因子研究进展[J].动物医学进展,2007,28(6):66-69. 被引量:6
  • 5Olesen H V, Moiler J K. Enterococcal infections.Clinical findings and treatment considering antibiotic resistance in Denmark[J]. Ugesker Laeger,2002,164( 18):2386-2390. 被引量:1
  • 6Sanchez-anchez-siols, Perez-Giraldo C, Martin P, et al. Pathogenicity of Enterococcus spp.Characteristics of 169 hospital isolates[J].Enferm Infecc Microbiol Clin,2000,18(4): 165-169. 被引量:1
  • 7Su Ya, Selavik M C, Makinen K K, et al.Nucleotide sequence of the Gelatinase gene (gelE) from Enterococcus faecalis subsp. Liquefaciens[J].Infect Immun, 1991,59(1 ):415 -420. 被引量:1
  • 8Coburm P S, Gilmore M S. The Enterococcus faecalis cytolysin:a novel toxin active against eukaryotic and prokaryotic cells[J].Cell Microbiol,2003,5(10):661-669. 被引量:1
  • 9李湘燕,郑波,李耘,等.粪肠球菌生物膜形成与esp、gelE基因的相关性分析[C].第六届全国抗菌药物临床药理学术会议论文集,2006. 被引量:1
  • 10Nakayama J, Tanaka E, Karuyama R, et al. Siamycin attenuates fsr Quorum Sensing mediated by a Gelatinase biosynthesis-activating pheromone in Enterococcus faecalis[J].J Bacteriol,2007,189(4): 1358- 1359. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部